NCT07516015 2026-04-07
Clinical Effectiveness and Safety of SHR-A1811 in Chinese Patients With HER2-Altered NSCLC
Nanjing Tianyinshan Hospital
Not yet recruiting
Nanjing Tianyinshan Hospital
Tianjin Medical University Cancer Institute and Hospital
The Netherlands Cancer Institute